Hoogtepunten tweede kwartaal De eerste zes maanden van 2015 “We zijn verheugd over de verdere verbetering van onze operationele resultaten in het tweede kwartaal van 2015, met name dankzij een sterke groei van de vergelijkbare omzet bij Healthcare en forse margeverbeteringen bij Consumer Lifestyle en Lighting. Hoewel we positief zijn over onze vooruitgang in het algemeen en met name over de resultaten van Healthcare in de Verenigde Staten, zijn we in toenemende mate bezorgd over het mondiale macro-economische klimaat, met name in China, Rusland en Latijns-Amerika. Bij Healthcare hebben we in het kwartaal aanzienlijke verbeteringen van de operationele marge gerealiseerd. Dit werd grotendeels tenietgedaan door een omvangrijk negatief wisselkoerseffect op de marge, verdere investeringen in groeimogelijkheden, en kosten gerelateerd aan de aanzienlijke inspanningen om onze kwaliteitsbeheersystemen te blijven verbeteren. We constateren tevens dat de Chinese markt lastiger wordt, met als gevolg dat de orders zijn teruggelopen. We zijn verheugd over de vooruitgang die wordt geboekt bij het opvoeren van de productie en leveringen vanuit onze productiefaciliteit in Cleveland, hoewel er nog meer werk moet worden verzet. Bij Consumer Lifestyle hebben we de operationele resultaten verder verbeterd, met name als gevolg van uitstekende prestaties bij Health & Wellness. Zoals al eerder aangegeven leidde de fasering bij de introductie van nieuwe producten tot een uitzonderlijk sterke groei in het eerste kwartaal, met als gevolg een lager groeipercentage in het kwartaal dat volgde. Over het geheel viel de vergelijkbare omzetgroei in de eerste helft van 2015 ruim binnen het middelhoge tot hoge enkelcijferige groeisegment. Bij Lighting realiseerden we opnieuw een sterke omzetgroei en een verbeterde winstgevendheid van onze LED-activiteiten. Tegelijkertijd wisten we het aantrekkelijke kasstroom- en winstgevendheidsprofiel van onze conventionele verlichtingsactiviteiten te behouden door onze productiefaciliteiten proactief te optimaliseren en kosten stringent te beheersen, dit ondanks de aanzienlijk teruggelopen markt. Als wereldwijd toonaangevende aanbieder van verlichtingsoplossingen hebben we vertrouwen in ons vermogen om leiding te geven aan de transformatie in deze sector. Kijkend naar de toekomst blijven we een bescheiden omzetgroei in 2015 en een verbetering van de operationele resultaten over het jaar verwachten. Ofschoon we bezorgd zijn over de invloed van het lastigere mondiale macro-economische klimaat op de resultaten, verwachten we een verdere verbetering van de operationele resultaten in 2016, waarmee de onderliggende kracht van onze activiteiten verder wordt versterkt. Op onze Capital Markets Day op 15 september a.s. zullen we nadere informatie geven over de resultaatontwikkeling bij HealthTech en Lighting Solutions." klik hier voor het volledige Engelstalige persbericht Quarterly Report Presentation Q2 2015 - Quarterly Results Presentation Conference call and audio webcast A conference call with Frans van Houten, CEO, and Ron Wirahadiraksa, CFO, to discuss the results, will start at 10:00AM CET. A live audio webcast of the conference call will be available through the link below. Q2 2015 conference call audio webcast More information about Frans van Houten and Ron Wirahadiraksa
Frans van Houten, CEO:
Steve Klink Joost Akkermans
Philips Group Communications
Tel: +31 6 10888824
E-mail: steve.klink@philips.com
Philips Group Communications
Tel.: +31 6 3175 8996
E-mail: joost.akkermans@philips.com
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 106,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.
This document and the related oral presentation, including responses to questions following the presentation, contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements. These factors include but are not limited to domestic and global economic and business conditions, developments within the euro zone, the successful implementation of Philips’ strategy and the ability to realize the benefits of this strategy, the ability to develop and market new products, changes in legislation, legal claims, changes in exchange and interest rates, changes in tax rates, pension costs and actuarial assumptions, raw materials and employee costs, the ability to identify and complete successful acquisitions, including Volcano, and to integrate those acquisitions into the business, the ability to successfully exit certain businesses or restructure the operations, the rate of technological changes, political, economic and other developments in countries where Philips operates, industry consolidation and competition. As a result, Philips’ actual future results may differ materially from the plans, goals and expectations set forth in such forward-looking statements. For a discussion of factors that could cause future results to differ from such forward-looking statements, see the Risk management chapter included in the Annual Report 2014. Third-party market share data Statements regarding market share, including those regarding Philips’ competitive position, contained in this document are based on outside sources such as research institutes, industry and dealer panels in combination with management estimates. Where information is not yet available to Philips, those statements may also be based on estimates and projections prepared by outside sources or management. Rankings are based on sales unless otherwise stated. Use of non-GAAP information In presenting and discussing the Philips Group financial position, operating results and cash flows, management uses certain non-GAAP financial measures. These non-GAAP financial measures should not be viewed in isolation as alternatives to the equivalent IFRS measures and should be used in conjunction with the most directly comparable IFRS measures. Non-GAAP financial measures do not have standardized meaning under IFRS and therefore may not be comparable to similar measures presented by other issuers. A reconciliation of these non-GAAP measures to the most directly comparable IFRS measures is contained in this document. Further information on non-GAAP measures can be found in the Annual Report 2014. Use of fair-value measurements In presenting the Philips Group financial position, fair values are used for the measurement of various items in accordance with the applicable accounting standards. These fair values are based on market prices, where available, and are obtained from sources that are deemed to be reliable. Readers are cautioned that these values are subject to changes over time and are only valid at the balance sheet date. When quoted prices or observable market data are not readily available, fair values are estimated using appropriate valuation models and unobservable inputs. Such fair value estimates require management to make significant assumptions with respect to future developments, which are inherently uncertain and may therefore deviate from actual developments. Critical assumptions used are disclosed in the Annual Report 2014. Independent valuations may have been obtained to support management’s determination of fair values. Presentation All amounts are in millions of euros unless otherwise stated. All reported data is unaudited. Financial reporting is in accordance with the accounting policies as stated in the Annual Report 2014, unless otherwise stated. In 2014, we announced plans to establish two standalone companies focused on the HealthTech and Lighting Solutions opportunities. The proposed separation of the Lighting business impacts all businesses and markets as well as all supporting functions and all assets and liabilities of the Group. Philips expects the separation will take approximately 12-18 months. We expect to continue reporting in the existing structure until the changes in the way we allocate resources and analyze performance in the new structure have been completed.